MH

MindWalk Holdings Corp.

HYFT·NASDAQ

$1.82

+6.1%
HealthcareBiotechnology

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

At a Glance

Live Snapshot
Market Cap$84.87M
EPS-0.9100
P/E Ratio-2.00
Earnings Date03/26/2026

hyft

Interest Expense

Last Annual Value

293.00K

3-Year CAGR

51%

5-Year CAGR

-27%

10-Year CAGR

97%

MH

MindWalk Holdings Corp. Competitors Analysis of Interest Expense

HYFT · NASDAQ
CompanyInterest Expense
CAGR 3Y
CAGR 5Y
CAGR 10Y
293.00K
113.8%-19.4%41.2% 
0.00
N/AN/AN/A
71.00K
-4.7%-35.3%N/A
1.60M
0.8%161.9%N/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
CLNN logo
Clene Inc.
NASDAQ:CLNN
2.68M
-16.2%25.3%N/A
CRVO logo
CervoMed Inc.
NASDAQ:CRVO
0.00
N/AN/AN/A
0.00
N/AN/AN/A
XBIT logo
XBiotech Inc.
NASDAQ:XBIT
88.00K
N/AN/AN/A
IMA logo
ImageneBio Inc
NASDAQ:IMA
0.00
N/AN/AN/A
MH

MindWalk Holdings Corp. Fair Value Envelope

HYFT · NASDAQ

Our analysis suggests that HYFT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.82, this represents a potential HIDDEN relative to our calculated worth for MindWalk Holdings Corp..

Intrinsic Value
Current Price: $1.82